GlassScriptPhysician profile
Michael C Friedle
NPI 1730471749
$12,863.91
in general payments reported to CMS, 2019-2025
16 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,098 · 2020: $3,321 · 2021: $6,207 · 2022: $869 · 2023: $134 · 2024: $115 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $333 · Travel and Lodging: $37.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $332.57 |
| Travel and Lodging | $37.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,046.24 | 2019-2025 | Da Vinci Surgical System |
| Tela Bio, INC. | $2,064.56 | 2020-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Davol INC. | $299.96 | 2020-2023 | Arista Ah Flexitip |
| Mimedx Group, INC. | $135.55 | 2024-2025 | |
| Medtronic, INC. | $88.23 | 2021-2023 | Dextile |
| Allergan, INC. | $50.99 | 2022 | |
| Innovation Technologies INC | $34.00 | 2022 | |
| Baxter Healthcare | $27.47 | 2022 | |
| Integra Lifesciences Corporation | $18.57 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Myriad Genetic Laboratories, INC. | $17.50 | 2021 | |
| Innocoll Pharmaceuticals Limited | $17.12 | 2022 | |
| Covidien LP | $16.26 | 2019 | |
| Kci USA, INC. | $15.56 | 2019 | |
| Merit Medical Systems INC | $14.66 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $13.45 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reprise Biomedical, INC. | $3.79 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Friedle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.